Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works by Sorli, Christopher H.
Results: 11
1
2
53-OR: Efficacy of Efpeglenatide in Patients with Obesity and Prediabetes: A Subanalysis of the BALANCE 205 Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-53-OR
- By:
- Publication type:
- Article
3
1023-P: Do Baseline Characteristics Impact Efficacy of Efpeglenatide QW in Uncontrolled Type 2 Diabetes?
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1023-P
- By:
- Publication type:
- Article
4
1014-P: Relationship between Glycemic Control and Weight Loss with Once-Weekly Efpeglenatide in Uncontrolled Type 2 Diabetes: A Subanalysis of EXCEED 203.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1014-P
- By:
- Publication type:
- Article
5
1001-P: Effects of Efpeglenatide on Body Weight, BMI, and Waist Circumference in Patients With Obesity Without Diabetes Stratified by Baseline Characteristics: A Subanalysis of BALANCE 205.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1001-P
- By:
- Publication type:
- Article
6
Identification of p70 and p80 Associations With Class II MHC Molecules and I<sub>i</sub>.
- Published in:
- American Journal of Hematology, 1990, v. 35, n. 3, p. 157, doi. 10.1002/ajh.2830350304
- By:
- Publication type:
- Article
7
Testing for cell surface forms of class II major histocompatibility complex antigens and I<sub>i</sub> by radioiodination, biotinylation, and membrane immunofluorescence.
- Published in:
- American Journal of Hematology, 1989, v. 30, n. 1, p. 4, doi. 10.1002/ajh.2830300103
- By:
- Publication type:
- Article
8
Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1292, doi. 10.1111/dom.14032
- By:
- Publication type:
- Article
9
Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1176, doi. 10.1111/dom.14020
- By:
- Publication type:
- Article
10
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2429, doi. 10.1111/dom.13824
- By:
- Publication type:
- Article
11
NOD mice have a generalized defect in their response to transplantation tolerance induction.
- Published in:
- 1999
- By:
- Publication type:
- journal article